Arquivos do dia: Maio 3, 2022
Diretriz ATS/ERS/JRS/ALAT | Fibrose pulmonar idiopática e fibrose pulmonar progressiva em adultos.
3 Mai, 2022 | 16:56h
Comentário no Twitter (fio – clique para saber mais)
🔥Finally out online: the latest multisocietal guidance defining progression in fibrotic lung disease🫁 has arrived!
These long-awaited guidelines help better clarify disease definition and guide treatmenthttps://t.co/LVuoVdZRj2
What does this mean? Hang on to your hats! 🧵1/n pic.twitter.com/3jvFGSfSuI
— Deji Adegunsoye (@drdayjee) April 29, 2022
Diretriz AAP para cuidado de fim de vida pediátrico.
3 Mai, 2022 | 16:54hGuidance for Pediatric End-of-Life Care – Pediatrics
Diretriz relacionada: End of life care for infants, children and young people with life-limiting conditions: planning and management – National Institute for Health and Care Excellence
Relatório CDC | Hepatite aguda e infecção por adenovírus em crianças.
3 Mai, 2022 | 16:52hComentários:
CDC releases new clinical details in cases of unusual hepatitis in children – CNN
CDC report finds no Covid link in children’s hepatitis cases in Alabama – NBC News
Conteúdos relacionados:
Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization
WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT
Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch
U.S., U.K. investigating unusual cases of hepatitis in young children – STAT
Mysterious liver illness seen in kids in US, Europe – Associated Press
Comentários no Twitter
Report from Alabama of acute hepatitis & adenovirus infection in young kids, Oct 21-Feb 22. 9 cases, all had adenovirus, 5/5 tested +ve for Adenovirus type 41. No epi links found. All under 6 yrs of age, immunocompetent, & no significant comorbidities. https://t.co/DcgcfN3KHo
— Andrew Lee (@andrewleedr) April 29, 2022
New report from @CDCMMWR on the 9 episodes of severe acute hepatitis in children from Alabama
All 9 positive for Adenovirus on whole blood PCR (all 5 samples sequences were type 41)
None PCR positive for #SARSCoV2
HT @tonisoriano66 https://t.co/h9LmHeVHEf
— Alasdair Munro (@apsmunro) April 29, 2022
ECDC publica Avaliação Rápida de Risco – Aumento nos casos de hepatite aguda grave de etiologia desconhecida em crianças.
3 Mai, 2022 | 16:50hConteúdos relacionados:
Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization
WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT
Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch
U.S., U.K. investigating unusual cases of hepatitis in young children – STAT
Mysterious liver illness seen in kids in US, Europe – Associated Press
Pfizer afirma que o tratamento de COVID com Paxlovid não previne infecção domiciliar.
3 Mai, 2022 | 16:46hPfizer says COVID treatment Paxlovid fails to prevent infection of household members – Reuters
Comentário no Twitter
Pfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in people living with someone who had been exposed to the virus. https://t.co/95zphEYaxc
— Reuters Health (@Reuters_Health) April 29, 2022
Estudo randomizado | Fentermina/topiramato para tratamento de obesidade na adolescência.
3 Mai, 2022 | 16:45hPhentermine/Topiramate for the Treatment of Adolescent Obesity – NEJM Evidence
Comentário no Twitter
This RCT evaluated phentermine/topiramate in adolescents ages 12 to <17 yrs with high BMIs over a 56 week period. At both mid- and top-doses, treatment significantly reduced BMI and waist circumference compared to placebo. https://t.co/HbCZOAlZPf@PedsEndoSociety #PedsEndo2022 pic.twitter.com/nB5juqxyA0
— NEJM Evidence (@NEJMEvidence) April 30, 2022
Estudo randomizado | Monitoramento remoto digital com cuidado padrão vs. cuidado padrão em pacientes tratados com agentes anticâncer orais.
3 Mai, 2022 | 16:43hDigital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial – Nature Medicine (se o acesso a este link for pago, tente este)
Comentário no Twitter
A phase 3 clinical trial evaluating the impact of a digital nurse navigator-led system in patients receiving oral #cancer treatment shows that remote monitoring with a smartphone results in improved patient experience & optimizes resources @GustaveRoussy https://t.co/N8fEXb00r7
— Nature Medicine (@NatureMedicine) April 26, 2022
Estudo randomizado | Eficiência da avaliação por prontuário eletrônico de desfechos relatados pelo paciente após imunoterapia para câncer.
3 Mai, 2022 | 16:42hComentário convidado: An Assistive Electronic Patient-Reported Outcome Monitoring Intervention for Management of Immune-Related Toxic Effects—Moving Toward Efficiency and Scale – JAMA Network Open
Comentário no Twitter
This RCT aimed to compare the efficiency between ePRO and traditional follow up models in cancer immunotherapy among 278 patients from 28 hospitals, finding that an ePRO model can improve safety & QOL, and is less time consuming. https://t.co/KtpcNz0keb pic.twitter.com/EsmNyTkdfB
— JAMA Network Open (@JAMANetworkOpen) March 31, 2022
Diretrizes NICE para dor primária crônica: o que o clínico geral ocupado precisa saber.
3 Mai, 2022 | 16:40hDiretriz original: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain – National Institute for Health and Care Excellence
Recomendações de consenso | Padrões de qualidade para o tratamento de doença hepática gordurosa não alcoólica.
3 Mai, 2022 | 16:11hQuality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (necessário cadastro gratuito)
Diretrizes relacionadas:
Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports